Loading clinical trials...
Loading clinical trials...
Postpartum depression (PPD) represent around 15% of birth in developed countries. The context of the COVID-19 epidemy represents a possible source of additional emotional distress. The objective of th...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
Collaborators
NCT06277661 · Postpartum Depression, Postpartum Anxiety, and more
NCT06545760 · Low Birth Weight, Kangaroo Mother Care, and more
NCT07384273 · Postpartum Depression (PPD)
NCT07382336 · Postpartum Depression (PPD)
NCT07189936 · Post-Acute COVID-19 Syndrome, Postural Tachycardia Syndrome (POTS), and more
CHU Amiens
Amiens
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions